Rubicon Organics Inc (ROMJF)
0.30
+0.02
(+7.03%)
USD |
OTCM |
May 17, 13:26
Rubicon Organics Total Assets (Quarterly): 40.00M for Sept. 30, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 40.00M |
| June 30, 2023 | 42.33M |
| March 31, 2023 | 40.19M |
| December 31, 2022 | 41.34M |
| September 30, 2022 | 42.02M |
| June 30, 2022 | 41.85M |
| March 31, 2022 | 42.88M |
| December 31, 2021 | 43.01M |
| September 30, 2021 | 43.72M |
| June 30, 2021 | 45.82M |
| March 31, 2021 | 49.65M |
| Date | Value |
|---|---|
| December 31, 2020 | 40.05M |
| September 30, 2020 | 33.32M |
| June 30, 2020 | 33.62M |
| March 31, 2020 | 29.93M |
| December 31, 2019 | 30.45M |
| September 30, 2019 | 29.34M |
| June 30, 2019 | 25.54M |
| March 31, 2019 | 22.61M |
| December 31, 2018 | 20.80M |
| September 30, 2018 | 24.11M |
| December 31, 2017 | 17.43M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
25.54M
Minimum
Jun 2019
49.65M
Maximum
Mar 2021
38.61M
Average
40.77M
Median
Total Assets (Quarterly) Benchmarks
| Acasti Pharma Inc | 76.18M |
| Aurinia Pharmaceuticals Inc | 548.06M |
| Edesa Biotech Inc | 6.475M |
| Lexaria Bioscience Corp | 6.352M |
| Xenon Pharmaceuticals Inc | 919.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 12.83M |
| Shareholders Equity (Quarterly) | 27.18M |
| Debt to Equity Ratio | 0.2872 |
| Current Ratio | 3.479 |
| Net Debt Paydown Yield | 7.59% |